Details of Protein
| General Information of Protein (ID: PRT01636) | |||||
|---|---|---|---|---|---|
| Name | Glutamate-cysteine ligase modifier (GCLM) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
GCS light chain; Gamma-ECS regulatory subunit; Gamma-glutamylcysteine synthetase regulatory subunit; Glutamate--cysteine ligase modifier subunit; Gclm; Glclr
|
||||
| Gene Name | Gclm | Gene ID | |||
| UniProt ID | |||||
| Family | Oxidoreductases (EC 1) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MGTDSRAAGALLARASTLHLQTGNLLNWGRLRKKCPSTHSEELRDCIQKTLNEWSSQISP
DLVREFPDVLECTMSHAVEKINPDEREEMKVSAKLFIVGSNSSSSTRSAVDMACSVLGVA QLDSVIMASPPIEDGVNLSLEHLQPYWEELENLVQSKKIVAIGTSDLDKTQLEQLYQWAQ VKPNSNQVNLASCCVMPPDLTAFAKQFDIQLLTHNDPKELLSEASFQEALQESIPDIEAQ DWVPLWLLRYSVIVKSRGIIKSKGYILQAKRRGS |
||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | ||||||
| Cytidine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Cytidine concentration: increase (FC = 1.60) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of cytidine levels compared with control group. | |||||
| Deoxyuridine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Deoxyuridine concentration: increase (FC = 2.30) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of deoxyuridine levels compared with control group. | |||||
| S-Adenosylmethionine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | S-Adenosylmethionine concentration: decrease (FC = 0.75) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of s-adenosylmethionine levels compared with control group. | |||||
| Lipids and lipid-like molecules | ||||||
| Butyrylcarnitine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Butyrylcarnitine concentration: decrease (FC = 0.52) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of butyrylcarnitine levels compared with control group. | |||||
| Organic acids and derivatives | ||||||
| Aspartic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Aspartic acid concentration: increase (FC = 1.30) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of aspartic acid levels compared with control group. | |||||
| Glutamic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Glutamic acid concentration: increase (FC = 1.70) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of glutamic acid levels compared with control group. | |||||
| Glutathione | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Glutathione concentration: decrease (FC = 0.05) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of glutathione levels compared with control group. | |||||
| Lactic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Lactic acid concentration: decrease (FC = 0.67) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of lactic acid levels compared with control group. | |||||
| N6-Acetyl-L-lysine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | N6-Acetyl-L-lysine concentration: increase (FC = 1.50) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of N6-acetyl-L-lysine levels compared with control group. | |||||
| Oxidized glutathione | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Oxidized glutathione concentration: decrease (FC = 0.24) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of oxidized glutathione levels compared with control group. | |||||
| Organic nitrogen compounds | ||||||
| Choline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Choline concentration: increase (FC = 1.80) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of choline levels compared with control group. | |||||
| Organic oxygen compounds | ||||||
| Acetyl-CoA | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Acetyl-CoA concentration: increase (FC = 1.60) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of acetyl-CoA levels compared with control group. | |||||
| Gluconic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Gluconic acid concentration: increase (FC = 2.20) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the increase of gluconic acid levels compared with control group. | |||||
| Organoheterocyclic compounds | ||||||
| Thiamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Knockout of Gclm | |||||
| Induced Change | Thiamine concentration: decrease (FC = 0.63) | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
| Details | It is reported that knockout of Gclm leads to the decrease of thiamine levels compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Hepatic metabolic adaptation in a murine model of glutathione deficiency. Chem Biol Interact. 2019 Apr 25;303:1-6. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

